Berson F G, Epstein D L, Grant W M, Hutchinson B T, Dobbs P C
Arch Ophthalmol. 1980 Jun;98(6):1051-4. doi: 10.1001/archopht.1980.01020031041005.
Patients with chronic glaucoma had a carefully scheduled series of intraocular pressure measurements before and after taking acetazolamide for one week at the following dosages: none, 500 mg of sustained-release capsules once a day, 500 mg of capsules twice a day, and 250 mg of tablets four times a day. A capsule taken once a day, which is better tolerated than one taken twice a day by some patients, offers a substantial pressure-lowering effect that lasts at least 23 hours, although the magnitude of the pressure lowering is less than with higher dosages. One capsule twice a day appears to be as effective in the regulation of IOP as one tablet four times a day. The 45% reduction in outflow pressure is achieved with an acetazolamide serum concentration in the range of 15 to 20 micrograms/mL.
慢性青光眼患者在服用乙酰唑胺一周前后,按照以下剂量进行了一系列精心安排的眼压测量:不服药、每天服用一次500毫克缓释胶囊、每天服用两次500毫克胶囊以及每天服用四次250毫克片剂。一些患者认为,每天服用一次胶囊的耐受性优于每天服用两次,它能产生显著的降压效果,且至少持续23小时,尽管降压幅度小于高剂量服用时。每天服用两次胶囊在调节眼压方面似乎与每天服用四次片剂一样有效。当乙酰唑胺血清浓度在15至20微克/毫升范围内时,流出压可降低45%。